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Background: Steroid-sensitive idiopathic nephrotic syndrome (SSINS) is most often encountered in sporadic cases
of minimal change disease (MCD). Only rare cases of familial forms of MCD have been reported and most of them
only in one generation. The scarcity of data has precluded unraveling the underlying genetic defect and candidate
gene approaches have been unsuccessful. Here we report two families with related SSINS cases and review the
related literature.
Case presentation: Two siblings and a cousin (first family), and a father and his son (second family), are reported
with SSINS due to MCD. Patients have been followed up for more than 12 years and a renal biopsy was performed
in three cases, demonstrating typical features of MCD. The course of the disease was remarkable because of several
relapses treated with steroids. In three cases, mycophenolate mofetil or cyclosporine was added.
Conclusion: Familial SSINS due to MCD is extremely rare and no genetic defect has been identified so far.
Reporting cases of hereditary MCD will allow further genetic studies which will ultimately help unravel the
molecular basis of this disease.
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Idiopathic nephrotic syndrome (INS) in children is
caused by various entities that differ in their histopatho-
logical forms and their clinical course [1]. Minimal
change disease (MCD) and focal segmental glome-
rulosclerosis (FSGS) are the most common causes of
INS representing 80% and 20% of the cases respectively
[1]. The clinical outcome of INS is determined by the
responsiveness to treatment by steroids. Most steroid-
sensitive INS (SSINS) are due to MCD, while steroid-
resistant INS (SRINS) are mostly represented by FSGS.
Although INS is well known as a sporadic disease, fami-
lial occurrences with autosomal dominant or recessive
mode of inheritance have been described especially in
FSGS forms [2]. Several genes have been associated with
or shown to be causative for some specific forms of INS,
mostly steroid-resistant, including NPHS1, NPHS2, PLCE1,
WT1, ACTN4, TRPC6, CD2AP, APOL1 or INF2 [3]. How-* Correspondence: Olivier.Bonny@chuv.ch
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reproduction in any medium, provided the orever, reports of familial MCD are scarce and no causal
gene has been identified yet. Here, we describe five cases
of steroid sensitive MCD in two non-consanguineous fa-
milies and perform a review of the literature. The objective
of our report is to encourage physicians to identify and
characterize genetic causes of MCD. This may help to
understand more precisely the pathophysiological mecha-
nisms of INS and provide a first step toward the identifica-
tion of the underlying genetic cause.
Cases presentation
Family 1
We describe a Portuguese non-consanguineous family
(see pedigree: Figure 1) in which two siblings (cases 1 and
2) and one cousin (case 3) were diagnosed with MCD
INS.
Case 1
A 6 year old boy, with no previous medical history,
presented with fatigue and facial edema. Physical exam-
ination showed moderate periorbital edema. Blood pres-
sure was within normal range for age (105/69 mmHg).al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and






Figure 1 Extensive pedigree of the first family. Three members
of this Portuguese non-consanguineous family were affected by
steroid-sensitive nephrotic syndrome, type minimal change disease:
two affected siblings (cases 1 and 2) and the first cousin once
removed (case 3). The index case (case 1) is indicated by an arrow
head. The numbers inside figures indicate the number of males
(square), females (rounds) or non-specified sex (lozenges) of
the family.
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Abdomen was soft, not distended, and no mass, shifting
dullness or hepatosplenomegaly were found. He had nor-
mal male genitalia with mild scrotal edema. The dorsal
surfaces of hands and feet had mild pitting edema. Urine
analysis by dipstick showed 4+ proteinuria with no he-
maturia. Urine spot showed a nephrotic range proteinuria
(protein/creatinine ratio of 2000 g/mol). The blood che-
mistry panel was remarkable for plasma protein level of
35 g/l and serum albumin of 10 g/l. BUN and creatinine
levels were normal, and no electrolyte disturbance was
noted. The diagnosis of INS was posed and the patient
was treated with oral prednisone (60 mg/m2/day b.i.d.).
Feet edema and proteinuria gradually resolved over the
course of treatment. He was followed up as outpatient
and did monitor daily albuminuria with urine dipsticks.
Corticosteroids were tapered off progressively and
stopped. Three months later, the patient relapsed after a
minor respiratory infection with re-appearance of protei-
nuria. Treatment with steroids was re-initiated for two
months. Eighteen months later, the patient remains com-
pensated without steroids and has normal blood pressure
and normal renal function.
Case 2
The brother of case 1, a child with no previous medical
history, presented at 3 years of age with mild facial edema
without any other clinical sign. Blood pressure was normal.
Laboratory tests showed proteinuria of nephrotic range
(protein/creatinine ratio 750 g/mol). Blood chemistry
showed low levels of total protein (45 g/l) and serum albu-
min (18 g/l), but BUN and creatinine concentrations werenormal. INS was diagnosed and the infant was treated with
oral prednisone 60 mg/m2/day b.i.d. He was followed up
in the outpatient clinic and was monitoring proteinuria
with dipsticks every day. Edema and proteinuria gradually
resolved under treatment and steroids were tapered off
with an initial favorable course. However, 2 months after
the interruption of the corticosteroids treatment, the pa-
tient presented several relapses, all steroid-sensitive and
every time triggered by respiratory or gastro-intestinal viral
infections. A renal biopsy was performed and showed all
the typical features of MCD (Figure 2), but no sign of
FSGS. Immunofluorescence staining was negative. The pa-
tient was treated with mycophenolate mofetil (MMF) in
addition to steroids with favorable outcome. Steroids were
then progressively tapered down and stopped.
Asking for family history of the two siblings lead to
identification of a first cousin once removed with a history
of INS due to MCD (Figure 1). Of note, family history was
unremarkable for chronic kidney failure or renal graft.
Case 3
This now 14 year old boy was initially diagnosed with
nephrotic syndrome at the age of 2 and was successfully
treated with corticosteroids. He suffered from several re-
lapses and was treated with oral cyclophosphamide. A
renal biopsy at age 3 shows normal morphology at light
microscopy, in particular no glomerulosclerosis and
interstitial fibrosis (Figure 3). No electronic microscopy
has been available. Another round of cyclophosphamide
was given at age 4 due to several relapses. At age 4.5,
the child presented another relapse which was trea-
ted with low dose corticosteroids and cyclosporine was
introduced for a 12 month period. At age 8, another
relapse was treated with a full dose of corticosteroids
(60 mg/m2/day) with favorable response and was main-
tained afterwards at low dose on alternate days. A treat-
ment by mycophenolate mofetil (600 mg/m2/day) was
introduced. The course of the disease was since favor-
able with rarer relapse episodes. At the last follow up
(age 14), physical exam was normal with blood pressure
of 111/65 mmHg and serum creatinine level was in the
normal range.
Family 2
Here we describe a French non-consanguineous family
(see pedigree: Figure 4) in which a father and his son
(cases 4 and 5) were diagnosed with MCD INS.
Case 4
A 4 year old boy, with no previous medical history,
presented with periorbital edema. Blood pressure was
within normal range for age (100/59 mmHg). He had mild
edema of the dorsal surfaces of hands, feet and mild scrotal
edema. Urine analysis by dipstick showed 4+ proteinuria
A B
DC
Figure 2 Renal biopsy of case 2 showing normal morphology by light microscopy (H&E staining, panel A, magnification 100×, panel B,
magnification 400×). Electron microscopy reveals podocyte foot effacement without any other structural abnormality (panel C, magnification
11500× and panel D, magnification 15500×).
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proteinuria (protein/creatinine ratio of 2450 g/mol). The
blood chemistry panel was remarkable for plasma protein
level of 39 g/l and serum albumin of 12 g/l. BUN, creati-
nine levels were normal and no electrolyte disturbance was
noted. The diagnosis of INS was posed and the patient was
treated with oral prednisone (60 mg/m2/day b.i.d.). Pro-
teinuria resolved after 7 days of treatment and peripheral
edema gradually disappeared over the course of treatment.
He was followed up as outpatient and did monitor daily
albuminuria with urine dipsticks. Corticosteroids wereA
Figure 3 Renal biopsy of case 3. Normal light microscopy (H&E staining,tapered down progressively for 6 months and stopped.
Two months later, the patient presented a relapse possibly
induced by a respiratory infection. Treatment with steroids
was re-initiated at 60 mg/m2/day and subsequently
decreased, but at the doses of 20 mg/m2/day, proteinuria
relapsed. A biopsy was performed showing all the features
typical for MCD (Figure 5), with no sign of FSGS. Im-
munofluorescence staining was negative. Prednisone treat-
ment was increased to 60 mg/m2/day and mycophenolate
mofetil was added with a favorable outcome on protei-
nuria. Steroids were then progressively tapered down andB
panel A, magnification 200×, panel B, magnification 400×).
45
Figure 4 Pedigree of the second family. The index case is
indicated by an arrow head.
A
C
Figure 5 Renal biopsy of case 4 shows normal light microscopy (H&E
400×). Electron microscopy shows podocyte foot fusion (panel C, magnific
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sated without steroids, has normal blood pressure and nor-
mal renal function.
Case 5
The 37 year old father of case 4 was hospitalized at the
age of 10 for peripheral edema, nephrotic range protein-
uria and hypoalbuminemia without renal failure or arte-
rial hypertension. The diagnosis of nephrotic syndrome
was made and treated with prednisone that was tapered
off progressively over 6 months. The evolution was then
favorable without relapses. At present time, the patient
displays normal renal function, normal blood pressure of
120/78 mmHg and no proteinuria (protein/creatinine
ratio: 9 g/mol).
Conclusion
In the past years, many familial FSGS cases have been
reported and genetic studies have identified mutations in
several genes coding for proteins of the slit diaphragm
complex and the podocyte which leads to autosomal
recessive (NPHS1, NPHS2) or autosomal dominant
(ACTN4, CD2AP, TRPC6 genes) steroid-resistant FSGS
[1,4-6]. Identification of genes related to FSGS has con-
tributed significantly to a better understanding of the
molecular paths involved in SRINS and is an important
determinant for the course of the disease. For instance,
relapses in renal transplant recipient carrying FSGSB
D
staining, panel A, magnification 200×, panel B, magnification
ation 6600× and panel D, magnification D, 11500×).
Table 1 Reported siblings with SSINS
References Year Familial cases with SSINS Histopathological confirmation of MCD
Roy S et al. [10] 1971 Identical twins Biopsy performed in 2 cases
Moncrieff MW et al. [11] 1973 18 cases in 9 families Biopsy performed in 12 cases
White RH et al. [12] 1973 12 cases from 24 centers in Europe Biopsy performed in 12 cases
Bader BI et al. [13] 1974 1 affected sibling pairs Biopsy performed in 1 case
McEnery PT et al. [14] 1989 2 cases in a family Data not available
Awadalla NB et al. [15] 1989 3 cases in a family Biopsy performed in 3 cases
Fuchshuber A et al. [7] 2001 32 cases in 15 families Biopsy performed in 12 cases
Ruf RG et al. [9] 2003 7 cases in 3 families Biopsy performed in 2 cases
Landau D et al. [8] 2007 6 cases in 2 related families No biopsy performed
Roberts IS et al. [16] 2008 2 cases in a family Biopsy performed in one case
Motoyama O et al. [17] 2009 2 cases in a family No biopsy performed
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transplant recipients without any gene mutation [3]. But
while important genetic clues have been identified for fa-
milial steroid-resistant INS and FSGS, reports of genes
causative for familial steroid sensitive INS and MCD are
still lacking. This might be due to the low prevalence of
the disease and to the few numbers of cases described so
far. Here, we report two novel families with 5 cases of
MCD. We encourage clinicians to report their cases in
order to collect enough families to conduct genetic
studies.
Literature review (using PubMed Advanced Search
Builder, date: 1960–1980 with the following key words:
familial nephrotic syndrome, and the date: 1980–2011
using the following key words: familial minimal change
disease, familial nephrotic syndrome) of familial cases of
SSINS revealed several reported cases within siblings
(Table 1) and only sixteen families with SSINS affecting
two generations (Table 2). Several interesting features
taken from these reports may help in managing these
cases. In their report of fifteen families with childhood-Table 2 Reported familial cases with SSINS in two generation
References Year Familial cases with SSINS in two
generations
White RH et al. [12] 1973 A father and his daughter
Bader BI et al. [13] 1974 2 affected first cousins from a
consanguineous family
McEnery PT et al. [14] 1989 A father and his son
Two families with 2 affected first co
Awadalla NB et al. [15] 1989 3 cases in a family and a cousin
Landau D et al. [8] 2007 - 2 families with parent/child affecte
- 2 Bedouin consanguineous family
14 affected members
- 5 non-related Bedouin families wit
affected members
Motoyama O et al. [17] 2009 A father and a daughteronset SSINS, Fuchshuber et al. [7] reported that the clin-
ical course of the familial forms was equivalent to sporadic
SSINS cases. A strong heritability of the age of onset of
the disease was suggested. In this first large report of fa-
milial SSINS, linkage with the candidate gene NPHS2 was
excluded and the authors concluded the existence of a
distinct gene locus for familial SSINS. Landau et al. [8]
reported on several extensive Bedouin families affected by
SSINS with similar clinical course - in terms of age of on-
set, male predominance and spontaneous cure at puberty -
compared to those in sporadic cases. By linkage analysis,
the authors showed a complete absence of linkage with
the usual candidate genes loci implicated in nephrotic syn-
drome or other glomerulopathies and they advised for
more specific genome-wide screening with a denser
marker set. In three families with SSINS, Ruf et al. [9] were
able to pinpoint a locus on chromosome 2p12-p13.2, and
also demonstrated clear evidence for genetic locus hetero-
geneity upon examination of ten additional families with
SSINS. The rare cases of familial SSINS reported in the lit-
erature confirm that the disease course is similar tos
Histopathological confirmation of MCD
Biopsy of the daughter only
Biopsy performed in both cases
usins Data not available
Biopsy performed in all 3 cases
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FSGS nephrotic syndrome.
Cases of familial SSINS spread over two generations
have rarely been described (see list in Table 2). Outcome,
in terms of renal function and blood pressure, is usually
favorable [7] compared to familial FSGS [18-20].
As the majority of familial cases of SSINS reported in
the literature is limited to one generation of siblings
(Table 1), the first genetic inheritance pattern suggested
was autosomal recessive or a possible germinal mosai-
cism. However, description of familial SSINS cases in
two generations (Table 2) with transmission from father
to children broadens the disease inheritance possibilities
to autosomal dominant transmission model with variable
penetrance. Altogether, analysis of the data issued from
the literature does not allow definitive conclusions about
the inheritance pattern of familial MCD and is permis-
sive for different possible transmission hypothesis, in-
cluding autosomal recessive, autosomal dominant with
variable penetrance or genetic heterogeneity. In addition,
a more complex inheritance pattern associated with
oligogenic predisposition and possible environmental ef-
fects is also possible. More reports of familial MCD are
needed in order to understand the disease transmission
pattern.
In this report, case 1 presented with typical INS at age
six and the follow-up was marked by a single relapse oc-
curring three months after the interruption of the steroids.
Renal biopsy was not performed in that case due to rapid
favorable outcome. The second case presented with INS at
the age of 3 with an initial favorable disease course, later
complicated by frequent relapses. A renal biopsy confirmed
the diagnosis of MCD. The child eventually showed a fa-
vorable evolution after the introduction of MMF. Case 3, a
first cousin once removed, presented with a classical INS
at age 6 and the renal biopsy showed typical MCD. Despite
treatment with corticosteroids, frequent relapses were ob-
served and treated with cyclophosphamide, cyclosporine,
and finally, MMF. These 3 cases had normal renal function
(estimated GFR using the revised Schwartz formula were
96, 97 and 99 ml/min 1.73 m2 respectively) and blood pres-
sure. Pedigree of this family is compatible with an auto-
somal dominant inheritance with variable penetrance, but
other forms of heritability are possible. A de novo mutation
in this family of two affected siblings and their cousin
seems less probable though. In the second reported family,
renal outcome was also favorable and the pedigree is com-
patible with an autosomal dominant inheritance. Overall,
all familial cases of MCD reported here had a clinical pres-
entation in terms of age of onset, symptoms during the ini-
tial phase, renal morphology and outcome close to other
familial cases described in the literature.
We are aware of this report’s few limitations. First, it is
descriptive and does not propose precise genetic or mo-lecular mechanisms that could explain familial MCD.
However, this publication is meant to encourage further
reports of similar rare cases that, once collected, may
allow wider genetic analysis. Second, recent reports have
suggested a role of CD80 induction in the occurrence of
sporadic MCD [21]. We did not dose soluble CD80 in
the urine of the patients presented here and therefore
could not conclude about the possible value of this bio-
marker and this proposed pathophysiological mechanism
for familial MCD.
In summary, here we describe five cases issued from
two families with steroid sensitive INS occurring in two
generations. The clinical course of these cases was simi-
lar to sporadic INS regarding the age of onset, clinical
presentation and the presence of minor infection prior
to the onset of recurrences, response to treatment and
disease outcome. This confirms the few previous ob-
servations of familial MCD reported in the literature.
The aim of this paper is to emphasize the importance of
identifying these families in order to allow further gene-
tic analysis, determine mode of inheritance and under-
stand the mechanisms of INS appearance.
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